Children born in October are both more likely to be vaccinated against influenza and least likely to be diagnosed with influenza compared with children born in other months, finds a US study published by The BMJ today.
The results suggest that birth month is associated with both timing of flu vaccination and the likelihood of a flu diagnosis - and that October is the optimal time for young children to have a flu shot, in line with current recommendations.
Annual influenza vaccination is particularly important for young children, who are at higher risk of flu and severe infection requiring admission to hospital. Vaccination is recommended during September or October to maximise immunity during the peak flu season.
Among young children in the United States, preventive care visits tend to occur during birth months and are a convenient time to receive the influenza vaccine, but large scale studies of the optimal timing of vaccination are unavailable.
To address this, researchers set out to assess the optimal timing of influenza vaccination in young children.
Using health insurance claims data, they identified over 800,000 children aged 2-5 years who received an influenza vaccination between 1 August and 31 January during 2011-18. They then analysed rates of diagnosed influenza among these children by birth month.
After accounting for a range of potentially influential factors such as age, sex, existing conditions, healthcare use and family size, the results show that October was the most common month for children to be vaccinated.
Children born in October also had the lowest rate of influenza diagnosis. For example, among children born in August, the average rate of influenza diagnosis across flu seasons studied was 3% compared with 2.7% for children born in October and 2.9% for those born in December.
This is an observational study and the authors acknowledge that their findings are limited to insured children who received medical care. Nor can they rule out the possibility that other unmeasured factors may have influenced their results.
Nevertheless, results were similar after additional analyses to evaluate whether the relation between birth month and influenza risk was due to chance, providing greater confidence in their conclusions.
“Our findings suggest that US public health interventions focused on vaccination of young children in October may yield the best protection in typical flu seasons,” they say.
“The study’s findings are consistent with current recommendations promoting October vaccination,” they add.
[Ends]
Journal
The BMJ
Method of Research
Observational study
Subject of Research
People
Article Title
Optimal timing of influenza vaccination in young children: population based cohort study
Article Publication Date
21-Feb-2024
COI Statement
All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: no support from any organization for the submitted work; ABJ has received (in the past 36 months) consulting fees unrelated to this work from Bioverativ, Merck/Sharp/Dohme, Janssen, Edwards Life Sciences, Novartis, Amgen, Eisai, Otsuka Pharmaceuticals, Vertex Pharmaceuticals, Celgene, Sanofi Aventis, Precision Health Economics, and Analysis Group; ABJ has also received (in the past 36 months) income unrelated to this work from hosting the podcast Freakonomics, MD, and from book rights to Doubleday Books and has served as a testifying expert in the national multi-district opioid litigation; CMW has received (in the past 36 months) consulting fees unrelated to this work from Alosa Health, Analysis Group, Atheneum, Berkshire Hathaway Home Companies, Chronius, FVC Health, GLG, Guidepoint, NuvoAir, Ogilvy, Philips, Simbo, Substack, Tell Health, the New York Times, and the Wall Street Journal and income unrelated to this work from book rights to Doubleday Books; no other relationships or activities that could appear to have influenced the submitted work.